Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

The fucose salvage pathway inhibits invadopodia formation and extracellular matrix degradation in melanoma cells.

Keeley T, Lin S, Lester DK, Lau EK, Yang S.

PLoS One. 2018 Jun 20;13(6):e0199128. doi: 10.1371/journal.pone.0199128. eCollection 2018.

2.

Metachronous Hepatic Angiosarcoma Presenting as a Mimic of Recurrent Hepatocellular Carcinoma.

Lau EKC, Tsai B, Morrison H, Deftos M, Lin AY.

J Gastrointest Cancer. 2018 Apr 6. doi: 10.1007/s12029-018-0094-3. [Epub ahead of print] No abstract available.

PMID:
29623568
3.

Differentiation of opioid drug effects by hierarchical multi-site phosphorylation.

Just S, Illing S, Trester-Zedlitz M, Lau EK, Kotowski SJ, Miess E, Mann A, Doll C, Trinidad JC, Burlingame AL, von Zastrow M, Schulz S.

Mol Pharmacol. 2013 Mar;83(3):633-9. doi: 10.1124/mol.112.082875. Epub 2012 Dec 13.

4.

Desensitization and trafficking of μ-opioid receptors in locus ceruleus neurons: modulation by kinases.

Arttamangkul S, Lau EK, Lu HW, Williams JT.

Mol Pharmacol. 2012 Mar;81(3):348-55. doi: 10.1124/mol.111.076208. Epub 2011 Nov 23.

5.

Response of myeloma to the proteasome inhibitor bortezomib is correlated with the unfolded protein response regulator XBP-1.

Ling SC, Lau EK, Al-Shabeeb A, Nikolic A, Catalano A, Iland H, Horvath N, Ho PJ, Harrison S, Fleming S, Joshua DE, Allen JD.

Haematologica. 2012 Jan;97(1):64-72. doi: 10.3324/haematol.2011.043331. Epub 2011 Oct 11.

6.

Plasmonic crystal defect nanolaser.

Lakhani AM, Kim MK, Lau EK, Wu MC.

Opt Express. 2011 Sep 12;19(19):18237-45. doi: 10.1364/OE.19.018237.

PMID:
21935190
7.

Quantitative encoding of the effect of a partial agonist on individual opioid receptors by multisite phosphorylation and threshold detection.

Lau EK, Trester-Zedlitz M, Trinidad JC, Kotowski SJ, Krutchinsky AN, Burlingame AL, von Zastrow M.

Sci Signal. 2011 Aug 9;4(185):ra52. doi: 10.1126/scisignal.2001748.

8.

Recovery from mu-opioid receptor desensitization after chronic treatment with morphine and methadone.

Quillinan N, Lau EK, Virk M, von Zastrow M, Williams JT.

J Neurosci. 2011 Mar 23;31(12):4434-43. doi: 10.1523/JNEUROSCI.4874-10.2011.

9.

NF-kappaB inhibitors from Brucea javanica exhibiting intracellular effects on reactive oxygen species.

Kim JA, Lau EK, Pan L, De Blanco EJ.

Anticancer Res. 2010 Sep;30(9):3295-300.

10.

Enhanced modulation bandwidth of nanocavity light emitting devices.

Lau EK, Lakhani A, Tucker RS, Wu MC.

Opt Express. 2009 May 11;17(10):7790-9.

PMID:
19434110
11.

Strong optical injection-locked semiconductor lasers demonstrating > 100-GHz resonance frequencies and 80-GHz intrinsic bandwidths.

Lau EK, Zhao X, Sung HK, Parekh D, Chang-Hasnain C, Wu MC.

Opt Express. 2008 Apr 28;16(9):6609-18.

PMID:
18545364
12.

Scaling of resonance frequency for strong injection-locked lasers.

Lau EK, Sung HK, Wu MC.

Opt Lett. 2007 Dec 1;32(23):3373-5.

13.

Novel cascaded injection-locked 1.55-mum VCSELs with 66 GHz modulation bandwidth.

Zhao X, Parekh D, Lau EK, Sung HK, Wu MC, Hofmann W, Amann MC, Chang-Hasnain CJ.

Opt Express. 2007 Oct 29;15(22):14810-6.

PMID:
19550761
14.

Regulation of protein function by glycosaminoglycans--as exemplified by chemokines.

Handel TM, Johnson Z, Crown SE, Lau EK, Proudfoot AE.

Annu Rev Biochem. 2005;74:385-410. Review.

PMID:
15952892
15.

Chemokine-receptor interactions: GPCRs, glycosaminoglycans and viral chemokine binding proteins.

Lau EK, Allen S, Hsu AR, Handel TM.

Adv Protein Chem. 2004;68:351-91. Review.

PMID:
15500866
16.

Identification of the glycosaminoglycan binding site of the CC chemokine, MCP-1: implications for structure and function in vivo.

Lau EK, Paavola CD, Johnson Z, Gaudry JP, Geretti E, Borlat F, Kungl AJ, Proudfoot AE, Handel TM.

J Biol Chem. 2004 May 21;279(21):22294-305. Epub 2004 Mar 18.

17.

Chemokine structure and receptor interactions.

Handel TM, Lau EK.

Ernst Schering Res Found Workshop. 2004;(45):101-24. Review. No abstract available.

PMID:
14699797
18.

Examination of MCP-1 (CCL2) partitioning and presentation during transendothelial leukocyte migration.

Hardy LA, Booth TA, Lau EK, Handel TM, Ali S, Kirby JA.

Lab Invest. 2004 Jan;84(1):81-90.

19.

Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines.

Proudfoot AE, Handel TM, Johnson Z, Lau EK, LiWang P, Clark-Lewis I, Borlat F, Wells TN, Kosco-Vilbois MH.

Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1885-90. Epub 2003 Feb 5.

20.

Structural basis of chemokine sequestration by a herpesvirus decoy receptor.

Alexander JM, Nelson CA, van Berkel V, Lau EK, Studts JM, Brett TJ, Speck SH, Handel TM, Virgin HW, Fremont DH.

Cell. 2002 Nov 1;111(3):343-56.

21.

Molecular determinants for CC-chemokine recognition by a poxvirus CC-chemokine inhibitor.

Seet BT, Singh R, Paavola C, Lau EK, Handel TM, McFadden G.

Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):9008-13. Epub 2001 Jul 24.

22.

Two novel polymorphic sequences in the glucocerebrosidase gene region enhance mutational screening and founder effect studies of patients with Gaucher disease.

Lau EK, Tayebi N, Ingraham LJ, Winfield SL, Koprivica V, Stone DL, Zimran A, Ginns EI, Sidransky E.

Hum Genet. 1999 Apr;104(4):293-300.

PMID:
10369158
23.

Genotypic heterogeneity and phenotypic variation among patients with type 2 Gaucher's disease.

Tayebi N, Reissner KJ, Lau EK, Stubblefield BK, Klineburgess AC, Martin BM, Sidransky E.

Pediatr Res. 1998 May;43(5):571-8.

PMID:
9585001
24.

Prenatal lethality of a homozygous null mutation in the human glucocerebrosidase gene.

Tayebi N, Cushner SR, Kleijer W, Lau EK, Damschroder-Williams PJ, Stubblefield BK, Den Hollander J, Sidransky E.

Am J Med Genet. 1997 Nov 28;73(1):41-7.

PMID:
9375921
25.

Femoropopliteal artery reconstruction.

Lau EK, Pang RK.

Hawaii Med J. 1967 May-Jun;26(5):435-7. No abstract available.

PMID:
6046525
26.

Ruptured abdominal aneurysm. Report of four cases.

Lau EK, Pang RK.

Hawaii Med J. 1966 Jul-Aug;25(6):464-7. No abstract available.

PMID:
5941108

Supplemental Content

Support Center